Cargando…

DNA methylation profile of liver tissue in end-stage cholestatic liver disease

AIMS: In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes. PATIENTS & METHODS: Reduced representation bisulf...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Angela C, Juran, Brian D, Schlicht, Erik M, McCauley, Bryan M, Atkinson, Elizabeth J, Moore, Raymond, Heimbach, Julie K, Watt, Kymberly D, Wu, Tsung-Teh, LaRusso, Nicholas F, Gores, Gregory J, Sun, Zhifu, Lazaridis, Konstantinos N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096606/
https://www.ncbi.nlm.nih.gov/pubmed/35473391
http://dx.doi.org/10.2217/epi-2021-0343
_version_ 1784706014426169344
author Cheung, Angela C
Juran, Brian D
Schlicht, Erik M
McCauley, Bryan M
Atkinson, Elizabeth J
Moore, Raymond
Heimbach, Julie K
Watt, Kymberly D
Wu, Tsung-Teh
LaRusso, Nicholas F
Gores, Gregory J
Sun, Zhifu
Lazaridis, Konstantinos N
author_facet Cheung, Angela C
Juran, Brian D
Schlicht, Erik M
McCauley, Bryan M
Atkinson, Elizabeth J
Moore, Raymond
Heimbach, Julie K
Watt, Kymberly D
Wu, Tsung-Teh
LaRusso, Nicholas F
Gores, Gregory J
Sun, Zhifu
Lazaridis, Konstantinos N
author_sort Cheung, Angela C
collection PubMed
description AIMS: In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes. PATIENTS & METHODS: Reduced representation bisulfite sequencing was performed on liver tissue from 58 patients with primary sclerosing cholangitis (n = 13), primary biliary cholangitis (n = 20), alcoholic liver disease (n = 21) and live liver donors (n = 4). Pathway enrichment and network analysis were used to explore key genes/pathways. RESULTS: Both cholestatic liver diseases were characterized by global hypomethylation, with pathway enrichment demonstrating distinct genes and pathways associated with the methylome. CONCLUSIONS: This novel study demonstrated that differential methylation in cholestatic liver disease was associated with unique pathways, suggesting it may drive disease pathogenesis.
format Online
Article
Text
id pubmed-9096606
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-90966062022-05-16 DNA methylation profile of liver tissue in end-stage cholestatic liver disease Cheung, Angela C Juran, Brian D Schlicht, Erik M McCauley, Bryan M Atkinson, Elizabeth J Moore, Raymond Heimbach, Julie K Watt, Kymberly D Wu, Tsung-Teh LaRusso, Nicholas F Gores, Gregory J Sun, Zhifu Lazaridis, Konstantinos N Epigenomics Research Article AIMS: In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes. PATIENTS & METHODS: Reduced representation bisulfite sequencing was performed on liver tissue from 58 patients with primary sclerosing cholangitis (n = 13), primary biliary cholangitis (n = 20), alcoholic liver disease (n = 21) and live liver donors (n = 4). Pathway enrichment and network analysis were used to explore key genes/pathways. RESULTS: Both cholestatic liver diseases were characterized by global hypomethylation, with pathway enrichment demonstrating distinct genes and pathways associated with the methylome. CONCLUSIONS: This novel study demonstrated that differential methylation in cholestatic liver disease was associated with unique pathways, suggesting it may drive disease pathogenesis. Future Medicine Ltd 2022-04-27 2022-04 /pmc/articles/PMC9096606/ /pubmed/35473391 http://dx.doi.org/10.2217/epi-2021-0343 Text en © 2022 Konstantinos N. Lazaridis https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Article
Cheung, Angela C
Juran, Brian D
Schlicht, Erik M
McCauley, Bryan M
Atkinson, Elizabeth J
Moore, Raymond
Heimbach, Julie K
Watt, Kymberly D
Wu, Tsung-Teh
LaRusso, Nicholas F
Gores, Gregory J
Sun, Zhifu
Lazaridis, Konstantinos N
DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title_full DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title_fullStr DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title_full_unstemmed DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title_short DNA methylation profile of liver tissue in end-stage cholestatic liver disease
title_sort dna methylation profile of liver tissue in end-stage cholestatic liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096606/
https://www.ncbi.nlm.nih.gov/pubmed/35473391
http://dx.doi.org/10.2217/epi-2021-0343
work_keys_str_mv AT cheungangelac dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT juranbriand dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT schlichterikm dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT mccauleybryanm dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT atkinsonelizabethj dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT mooreraymond dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT heimbachjuliek dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT wattkymberlyd dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT wutsungteh dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT larussonicholasf dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT goresgregoryj dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT sunzhifu dnamethylationprofileoflivertissueinendstagecholestaticliverdisease
AT lazaridiskonstantinosn dnamethylationprofileoflivertissueinendstagecholestaticliverdisease